Pyrazine compounds for treating gpr119 related disorders
US2010022590A1
Novel compounds
BRPI0819989A2
Compound, pharmaceutical formulation, use of a compound, process for preparing a compound, and methods for treating or preventing conditions or diseases and for inhibiting angiogenesis
NZ584679A
A method and device for the serial ejection of two fluids comprising a spacer to retain a volume of a second fluid for rinsing
WO2008116898A1
Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase
BRPI0717946A2
8-SULPHONYL-1,3,4,8-TETRAHYDRO-2H- [1,4] OXAZEPINO [6,7-E] INDOL DERIVATIVE AND ITS USE AS 5-HT6 RECEIVER Binders
WO2008025799A1
Pyridazine compounds for treating gpr119 related disorders
WO2008003753A1
Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity
NZ573308A
Adenosine derivatives for the treatment of pain
CN101479290A
Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists
CA2643747A1
Autoimmune conditions and nadph oxidase defects
US2006293361A1
Substituted sulphonamide compound and uses thereof
CA2610315A1
Process for cultivating animal cells comprising the feeding of plant-derived peptones
AU2004252395A1
Methods for identifying agents, which regulate cytokines
EP1897881A2
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
AU2002311737B2
Method for identification of agents for the treatment of diabetes
CN101402601A
Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
EP1179014A1
Derivatives of the z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii
